NASDAQ Companies

MANCHESTER, United Kingdom and DUBLIN, Ireland and MILAN, Italy, Feb. 01, 2024 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings”, […]

WARRINGTON, Pa., Feb. 01, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company […]

BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) —  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in […]

CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop universal-RAS/RAF […]

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma […]

New contract adds to Evtec’s existing order book of $780 million Parts supplied by Evtec to be used in new […]

NOVI, Mich., Feb. 01, 2024 (GLOBE NEWSWIRE) — The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North […]

Highlights: Clarion’s Head of Psychiatry, Professor Suresh Sundram, has been approved by the TGA to prescribe MDMA for Post-traumatic Stress […]

– On track for PDUFA target action date of May 25, 2024 – CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) — […]

NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]